MedPath

Study of effect of vitamin E and aspirin in women with recurrent miscarriage

Phase 2
Conditions
Recurrent miscariage.
Pregnancy care of habitual aborter
Registration Number
IRCT2016022020035N2
Lead Sponsor
Vice chancellor for research, Kashan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
99
Inclusion Criteria

recurrent miscarriage patients with impaired uterine perfusion
Exclusion criteria: the use of hormonal contraceptives in the last 3 months; use of intrauterine contraceptive method; pregnant women; use of aspirin and vitamin E in the recent week

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
terine Artery Blood Flow Velocity. Timepoint: Baseline and Three Months After Begining of Treatment. Method of measurement: Ultrasonography.
Secondary Outcome Measures
NameTimeMethod
--. Timepoint: --. Method of measurement: --.
© Copyright 2025. All Rights Reserved by MedPath